Roussel GMP Fine Is Based On Biochimica Operating Profit For Cefaclor
Executive Summary
The $33 mil. fine levied against Roussel Uclaf (now part of Aventis) for cefaclor manufacturing violations is based on the firm's operating profit from the sale of the generic antibiotic.